The effect of immunodeficiency on cutaneous delayed-type hypersensitivity testing in HIV-infected women without anergy: implications for tuberculin testing

被引:0
作者
Klein, RS
Flanigan, T
Schuman, P
Smith, D
Vlahov, D
机构
[1] Montefiore Med Ctr, Dept Med, Div Infect Dis, Bronx, NY 10467 USA
[2] Montefiore Med Ctr, Dept Epidemiol & Social Med, Bronx, NY 10467 USA
[3] Albert Einstein Coll Med, Bronx, NY 10467 USA
[4] Miriam Hosp, Dept Med, Div Infect Dis, Providence, RI 02906 USA
[5] Brown Univ, Sch Med, Providence, RI 02912 USA
[6] Wayne State Univ, Sch Med, Dept Med, Div Infect Dis, Detroit, MI 48201 USA
[7] Ctr Dis Control & Prevent, Atlanta, GA USA
[8] Johns Hopkins Univ, Sch Hyg & Publ Hlth, Baltimore, MD USA
关键词
skin tests; delayed type hypersensitivity testing; tuberculin testing; HIV; women;
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
SETTING: A collaborative study in four urban medical centers in the United States. OBJECTIVE: To determine the effect of human immunodeficiency virus (HIV) infection and immunodeficiency on delayed type hypersensitivity (DTH) responses and the implications for interpretation of tuberculin reactions in non-anergic women with or at risk for HIV infection. DESIGN: Demographic and behavioral information, HIV antibody testing, CD4+ lymphocyte counts, and cutaneous responses to DTH testing with mumps, Candida, tetanus toroid, and tuberculin (purified protein derivative-PPD) antigens were obtained in 1184 women. RESULTS: Reactions to one or more of the four antigens occurred in 436 HIV-seropositive and 356 high-risk seronegative women. Among non-anergic women, HIV-seropositives were less likely (P less than or equal to 0.05) to react to mumps (62% vs 81%), tetanus (72% vs 84%), and PPD (13% vs 19%). Induration in HIV-seropositive reactors was associated with CD4+ cell level for mumps (P = 0.004) and tetanus (P < 0.001), but not for Candida or PPD, HIV-seropositive reactors with CD4+ cell counts >500/mm(3) did not have significantly smaller reactions than HIV-seronegatives for any antigen tested. PPD sizes were similar among HIV-seropositive reactors with CD4+ cell counts >500/mm(3) (12.4 +/- 7.4 mm) and HIV-seronegative reactors (12.0 +/- 8.3 mm); induration greater than or equal to 10 mm was seen in 16/173 (9.2%) seropositive women with CD4+ cell counts >500/mm3 and 41/356 (11.5%) seronegative women, respectively (P = 0.5). CONCLUSION: Among HIV-infected women able to react to a DTH antigen, induration in response to that antigen was relatively intact at CD4+ counts >500/mm3. This suggests that degree of immunodeficiency should be considered when interpreting PPD reactions in HIV-infected persons.
引用
收藏
页码:681 / 688
页数:8
相关论文
共 26 条
  • [1] BIRX DL, 1993, J ACQ IMMUN DEF SYND, V6, P1248
  • [2] BORLEFFS JCC, 1991, AIDS, V5, P110, DOI 10.1097/00002030-199101000-00020
  • [3] INSTABILITY OF DELAYED-TYPE HYPERSENSITIVITY SKIN-TEST ANERGY IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    CAIAFFA, WT
    GRAHAM, NMH
    GALAI, N
    RIZZO, RT
    NELSON, KE
    VLAHOV, D
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (19) : 2111 - 2117
  • [4] *CDC, 1989, MMWR-MORBID MORTAL W, V38, P236
  • [5] *CDC, 1991, MMWR-MORBID MORTAL W, V40, P27
  • [6] *CDCP, 1997, MMWR-MORBID MORTAL W, V46, P1
  • [7] Centers for Disease Control (CDC), 1989, MMWR-MORBID MORTAL W, V38, P243
  • [8] Reliability of anergy skin testing in persons with HIV infection
    Chin, DP
    Osmond, D
    PaceShafer, K
    Glassroth, J
    Rosen, MJ
    Reichman, LB
    Kvale, PA
    Wallace, JM
    Poole, WK
    Hopewell, PC
    Stansell, J
    Turner, J
    LeMaire, B
    Richer, B
    Au, J
    Coulson, A
    Clemente, V
    Shapiro, B
    Markowitz, N
    Saravolatz, LD
    Johnson, C
    Huitsing, J
    Krystoforski, A
    Mossar, M
    Hirschtick, R
    Mangura, BT
    Barnes, S
    Meiselman, L
    Manghisi, KK
    Schneider, RF
    Cardozo, C
    Kalb, TH
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 153 (06) : 1982 - 1984
  • [9] COLEBUNDERS RL, 1989, J ACQ IMMUN DEF SYND, V2, P576
  • [10] ACQUIRED IMMUNODEFICIENCY SYNDROME - EPIDEMIOLOGIC, CLINICAL, IMMUNOLOGICAL, AND THERAPEUTIC CONSIDERATIONS
    FAUCI, AS
    MACHER, AM
    LONGO, DL
    LANE, HC
    ROOK, AH
    MASUR, H
    GELMANN, EP
    [J]. ANNALS OF INTERNAL MEDICINE, 1984, 100 (01) : 92 - 106